Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PRQR – ProQR Therapeutics N.V.

ProQR Therapeutics N.V.
PRQR
$1.47
Name : ProQR Therapeutics N.V.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $154,882,960.00
EPSttm : -0.5
finviz dynamic chart for PRQR
ProQR Therapeutics N.V.
$1.47
3.92%
$0.06
PRQR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.21

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.01

EPS Last/This Y

-0.15

EPS This/Next Y

-0.06

Price

1.47

Target Price

8.95

Analyst Recom

1

Performance Q

-18.33

Upside

-542.2%

Beta

0.08

Ticker: PRQR




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11PRQR1.6150.020.00430
2026-05-12PRQR1.610.020.00430
2026-05-13PRQR1.710.020.00430
2026-05-14PRQR1.660.020.00430
2026-05-15PRQR1.60.010.00448
2026-05-18PRQR1.5150.010.00448
2026-05-19PRQR1.4350.010.00375
2026-05-20PRQR1.430.010.00375
2026-05-21PRQR1.430.010.00375
2026-05-22PRQR1.5550.010.00375
2026-05-26PRQR1.570.010.00375
2026-05-27PRQR1.570.010.00377
2026-05-28PRQR1.580.010.00379
2026-05-29PRQR1.590.010.00380
2026-06-02PRQR1.480.010.00382
2026-06-03PRQR1.4750.010.00432
2026-06-04PRQR1.5350.010.00452
2026-06-05PRQR1.510.010.00452
2026-06-08PRQR1.540.010.00477
2026-06-09PRQR1.4750.010.00477
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11PRQR1.62-58.6- -0.58
2026-05-12PRQR1.61-58.6- -0.58
2026-05-13PRQR1.71-58.6- -0.58
2026-05-14PRQR1.65-58.6- -0.58
2026-05-15PRQR1.59-58.6- -0.58
2026-05-18PRQR1.51- - -0.58
2026-05-19PRQR1.43- - -0.58
2026-05-20PRQR1.43- - -0.58
2026-05-21PRQR1.44- - -0.58
2026-05-22PRQR1.55- - -0.62
2026-05-26PRQR1.58- - -0.62
2026-05-27PRQR1.58- - -0.62
2026-05-28PRQR1.57- - -0.62
2026-05-29PRQR1.59- - -0.62
2026-06-01PRQR1.42- - -0.62
2026-06-02PRQR1.49- - -0.62
2026-06-03PRQR1.48- - -0.62
2026-06-04PRQR1.54- - -0.62
2026-06-05PRQR1.50- - -0.62
2026-06-08PRQR1.53- - -0.62
2026-06-09PRQR1.47- - -0.62
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11PRQR0.00-1.041.77
2026-05-12PRQR0.00-1.041.18
2026-05-13PRQR0.00-1.041.18
2026-05-14PRQR0.00-1.041.18
2026-05-15PRQR0.00-1.041.18
2026-05-18PRQR0.00-0.861.18
2026-05-19PRQR0.00-0.861.18
2026-05-20PRQR0.00-0.861.18
2026-05-21PRQR0.00-0.861.18
2026-05-22PRQR0.00-0.861.18
2026-05-26PRQR0.00-2.101.18
2026-05-27PRQR0.00-2.101.18
2026-05-28PRQR0.00-2.101.21
2026-05-29PRQR0.00-2.101.21
2026-06-02PRQR0.00-2.071.21
2026-06-03PRQR0.00-2.071.21
2026-06-04PRQR0.00-2.071.21
2026-06-05PRQR0.00-2.071.21
2026-06-08PRQR0.00-2.071.21
2026-06-09PRQR0.00-2.071.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.15

Avg. EPS Est. Current Quarter

-0.19

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

Institutional Transactions

-2.07

Beta

0.08

Average Sales Estimate Current Quarter

5

Average Sales Estimate Next Quarter

5

Fair Value

Quality Score

11

Growth Score

28

Sentiment Score

93

Actual DrawDown %

83.8

Max Drawdown 5-Year %

-93.4

Target Price

8.95

P/E

Forward P/E

PEG

P/S

9.97

P/B

3.58

P/Free Cash Flow

EPS

-0.5

Average EPS Est. Cur. Y​

-0.62

EPS Next Y. (Est.)

-0.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-339.39

Relative Volume

0.78

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.62

EBIT Estimation

PRQR Healthcare
$1.47
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
13/25
Volume
9/15
Valuation
12/20
TP/AR
2/10
Options
5/10
RSI
43.9
Range 1M
30.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
18 /100
WEAK
Momentum
9/25
Growth
4/30
Estimates
0/20
Inst/Vol
0/15
Options
5/10
EPS Yr
-29.1%
EPS NY
-15.8%
52W%
7.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +508.8% upside
Quality
6/30
Valuation
16/30
Growth
0/25
Stability
5/10
LT Trend
4/5
Upside
+508.8%
Quality
11
ProQR Therapeutics N.V.
Sector: Healthcare
Industry: Biotechnology
Employees: 186
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
PRQR

Latest News

Caricamento notizie per PRQR
stock quote shares PRQR – ProQR Therapeutics N.V. Stock Price stock today
news today PRQR – ProQR Therapeutics N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch PRQR – ProQR Therapeutics N.V. yahoo finance google finance
stock history PRQR – ProQR Therapeutics N.V. invest stock market
stock prices PRQR premarket after hours
ticker PRQR fair value insiders trading